Previously, during blood perfusion over
collagen-coated surfaces; soluble or immobilized
heparin proteoglycans (HEP-PG) have been shown to block
thrombus growth. Our aim was to study the antithrombotic effect of locally applied
unfractionated heparin (UFH, 1 mg/ml), or rat mast cell-derived HEP-PG (MW 750 kD, 10 microg/ml) compared with saline in early (10 min) and late (3 days)
thrombus formation upon anastomosis of rat common femoral arteries. In both semiquantitative scanning electron microscopy (SEM) and quantitative platelet
Indium 111-labeling HEP-PG inhibited
thrombus growth in comparison with saline.
At 10 min, the extent of
thrombosis (scale 1-4) in SEM followed the order: saline (3.2+/-0.8) > UFH (2.8+/-1.0) > HEP-PG (1.8+/-0.8), and also
Indium 111-positive platelets (10(6)) accumulated on the anastomosed vessel in the same order 14.2 +/-7.2, 10.3 +/-5.0, and 7.7 +/-3.1 (saline vs. HEP-PG, p = 0.03 and 0.05, respectively). At 3 days all HEP-PG-treated vessels remained patent with only small mural thrombi, whereas 2/7 saline- and 1/7 UFH-treated anastomoses occluded and showed more
thrombosis overall. We conclude that locally administered HEP-PG inhibit arterial
thrombus growth in anastomosed small-sized arteries and could prevent thrombotic complications in (micro)
vascular surgery and arteriovenous shunts.